Semaglutide vs Cagrilintide
GLP-1 incretin vs long-acting amylin analog.
| Attribute | Semaglutide GLP-1 receptor agonist | Cagrilintide Long-acting amylin analog |
|---|---|---|
| Category | Weight Loss & Metabolism | Weight Loss & Metabolism |
| Best known for | Weight loss and blood sugar research | Satiety and amylin pathway research |
| In plain English | Semaglutide mimics the hormone your gut releases when you eat. The brain reads it as 'we're full,' appetite drops, and stomach emptying slows down. | Amylin is a hormone released with insulin that tells your brain you're full. Cagrilintide mimics it on a long schedule. |
| How it works | Activates the GLP-1 receptor in the pancreas, brain, and gut — increasing insulin secretion, slowing gastric emptying, and reducing appetite through hypothalamic signaling. | Activates amylin receptors, slowing gastric emptying and reducing food intake via the area postrema in the brain. |
| Researchers study | Glycemic control, weight reduction, cardiovascular outcomes, and emerging research in addiction and neuroinflammation. | Body weight reduction alone and combined with semaglutide (CagriSema). |
| Internet discussion | The internet talks about semaglutide constantly — 'Ozempic face,' food noise reduction, alcohol cravings dropping, and dose-titration questions. | Discussed as the secret to lifting GLP-1 weight loss plateaus. |
Semaglutide
Weight loss and blood sugar research
Semaglutide mimics the hormone your gut releases when you eat. The brain reads it as 'we're full,' appetite drops, and stomach emptying slows down.
Activates the GLP-1 receptor in the pancreas, brain, and gut — increasing insulin secretion, slowing gastric emptying, and reducing appetite through hypothalamic signaling.
Glycemic control, weight reduction, cardiovascular outcomes, and emerging research in addiction and neuroinflammation.
The internet talks about semaglutide constantly — 'Ozempic face,' food noise reduction, alcohol cravings dropping, and dose-titration questions.
Semaglutide is the reference GLP-1 agonist — well-studied for blood sugar control and significant weight reduction.
Cagrilintide
Satiety and amylin pathway research
Amylin is a hormone released with insulin that tells your brain you're full. Cagrilintide mimics it on a long schedule.
Activates amylin receptors, slowing gastric emptying and reducing food intake via the area postrema in the brain.
Body weight reduction alone and combined with semaglutide (CagriSema).
Discussed as the secret to lifting GLP-1 weight loss plateaus.
Cagrilintide is a long-acting amylin analog studied as an add-on to GLP-1 agonists for additional satiety and weight loss.